In biocatalysis, enzymes are used to accelerate chemical reactions. This plays a role in many areas, such as the production of beer, wine and cheese or the pharmaceutical industry. A research project at the English-medium Jacobs University led by Marcelo Fernandez-Lahore, Professor of Biochemical Engineering, aims to create a novel platform for facilitating the further processing of a wide range of biological products. “Our Nanofacil project will drastically simplify the application and implementation of biocatalytic processes in industrial practice,” says Fernandez-Lahore.
Enzymes enable important (industrial) chemical transformations under very mild conditions. Companies need fewer organic solvents and hazardous chemicals, and their energy consumption is reduced.
The use of enzymes therefore leads to more sustainable industrial practices. In particular, there is an increased demand for enzymes in the production of pharmaceuticals, flavors, fragrances and polymers.
Some time ago, scientists at Jacobs University developed a new way to apply the use of enzymes to industrial processes. This process is known as “nanoformulation”. Most enzymes are proteins; under production conditions they become unstable.
“Nanoformulation” makes enzymes more resistant and improves safety in production. The “Nanofacil” project follows on from this research. It is funded by the Central Innovation Program for SMEs of the Federal Ministry of Economics and Energy with around 175,000 euros over a period of three years. Two industrial partners from Germany and Finland are also involved.
About Jacobs University Bremen:
Studying in an international community. Obtaining a qualification to work on responsible tasks in a digitized and globalized society. Learning, researching and teaching across academic disciplines and countries. Strengthening people and markets with innovative solutions and advanced training programs. This is what Jacobs University Bremen stands for.
Established as a private, English-medium campus university in Germany in 2001, it is continuously achieving top results in national and international university rankings. Its almost 1,400 students come from more than 100 countries with around 80% having relocated to Germany for their studies. Jacobs University’s research projects are funded by the German Research Foundation or the EU Research and Innovation program as well as by globally leading companies.
For more information: www.jacobs-university.de
Facebook | YouTube | Twitter | Instagram | Weibo
Thomas Joppig | Jacobs University Bremen gGmbH
Corporate Communications & Public Relations
firstname.lastname@example.org | Tel.: +49 421 200-4504
Commercial registry: Amtsgericht Bremen, HRB 18117
President / Chairman of the Executive Board (Vorsitzender der Geschäftsführung): Prof. Dr. Michael Hülsmann
Managing Director (Geschäftsführer): Dr. Michael Dubbert
Chairman of the Board of Governors (Aufsichtsratsvorsitzender): Prof. Dr. Antonio Loprieno
Prof. Dr. Marcelo Fernandez-Lahore | Professor for Biochemical Engineering
email@example.com | Tel.: +49 421 200-3239
Thomas Joppig | idw - Informationsdienst Wissenschaft
From a plant sugar to toxic hydrogen sulfide
19.12.2018 | Universität Konstanz
Gut microbiome regulates the intestinal immune system, researchers find
19.12.2018 | Brown University
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Information Technology
19.12.2018 | Physics and Astronomy
19.12.2018 | Life Sciences